Indofarma Tbk. vs Eureka Prima Jakarta Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Eureka Prima Jakarta Tbk. trades at Rp114 (market cap 641.82B). The key difference: Eureka Prima Jakarta Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | LCGP | |
|---|---|---|
Market Cap | 390.51B | 641.82B |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Eureka Prima Jakarta Tbk formerly Laguna Cipta Griya Tbk (the company) was established based on notarial deed No. 97 dated May 17, 20014 of Bambang Suwondo, S.H., notary in Jakarta and has been amended based on the deed No. 4 dated June 4, 2004 before notary H. Yunardi, S.H. The Company’s articles of association has been amended several times, most recently by notarial deed No. 40 of Fathiah Helmi, S.H., dated Jan 30, 2007, concerning among others, change the company's name.
Read more on LCGP →